US IPO Week Ahead: December kicks off with a 1 IPO week

Renaissance Capital2021-11-28

The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise $30 million in the first week of December. While the calendar is quiet at the moment, several IPOs ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

SilentWarrio
2021-11-29
SilentWarrio
Good Buy?
47776e2c
2021-11-29
47776e2c
👍
stormlee
2021-11-29
stormlee
Pls like thanks
- JeremyKok:
  hi. please like and comment back. thank you.
Yannick
2021-11-28
Yannick
Like pls
- Yannick:
  tks
- 7d918508:
  Ok
- JeremyKok:
  hi. please like and comment back. thank you.
- stormlee:
  Pls like thanks
bostonxsgp
2021-11-28
bostonxsgp
Nice
- ToTheMOON:
  Ok
- gky:
  ok
SamYYL
2021-11-28
SamYYL
Like
- stormlee回复SamYYL:
  Tq
- SamYYL:
  thanks
- stormlee:
  Pls like thanks
- Ahleepapa:
  Short
- Mtan23:
  Yes

发表看法

690

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1153242523?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-11-28 09:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1153242523","market":"us","top_or_hot":-1,"title":"US IPO Week Ahead: December kicks off with a 1 IPO week","media":"Renaissance Capital","content":"<div>\n<p>The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise $30 million in the first week of December.\nWhile the calendar is quiet at the moment, several IPOs ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/89065/US-IPO-Week-Ahead-December-kicks-off-with-a-1-IPO-week\">网页链接</a>\n\n</div>\n","source":"lsy1603787993745","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: December kicks off with a 1 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: December kicks off with a 1 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-28 09:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/89065/US-IPO-Week-Ahead-December-kicks-off-with-a-1-IPO-week><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise $30 million in the first week of December.\nWhile the calendar is quiet at the moment, several IPOs ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/89065/US-IPO-Week-Ahead-December-kicks-off-with-a-1-IPO-week\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NVCT","symbol_name":"Nuvectis Pharma, Inc.","start_time":0,"source_url":"https://www.renaissancecapital.com/IPO-Center/News/89065/US-IPO-Week-Ahead-December-kicks-off-with-a-1-IPO-week","article_id":"1153242523","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1153242523","pubTimestamp":1638063498,"columns":[],"sourceInfo":{"source_id":"lsy1603787993745","name":"Renaissance Capital"},"weMediaInfo":null,"summary":"The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise ","collect":0,"end_time":0,"defaultTopTitle":"renaissancecapital.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"NVCT":"Nuvectis Pharma, Inc."},"translate_title":"美国首次公开募股周：12月首次公开募股周为1周","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVCT":0.9},"content_text":"The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise $30 million in the first week of December.\nWhile the calendar is quiet at the moment, several IPOs are eligible to launch on Monday, including Indian IT services provider Coforge (CFRG.RC), cloud infrastructure platform HashiCorp (HCP), luxury fashion e-tailer Rue Gilt Group (RGG), rugged apparel brand 5.11 ABR(VXI), and Florida-based insurer TypTapInsurance Group (TYTP).\nPhase 1-ready biotech Nuvectis Pharma (NVCT) plans to raise $30 million at a $160 million market cap. The company is initially focused the development of innovative precision medicines for the treatment of serious unmet medical needs in oncology. Nuvectis is currently developing two preclinical candidates, with its lead candidate expected to begin a Phase 1 trial in the 4Q21.\n\nStreet research is expected to 12 companies in the week ahead, and lock-up periods will be expiring for up to four companies. For access to Street research and lock-up dates,sign up for a free trial of IPO Pro.\nIPO Market Snapshot\nThe Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 11/24/2021, the Renaissance IPO Index was down 1.1% year-to-date, while the S&P 500 was up 25.2%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Moderna (MRNA). The Renaissance International IPO Index was down 22.4% year-to-date, while the ACWX was up 7.4%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":600852838,"gmtCreate":1638141659114,"gmtModify":1638141659287,"author":{"id":"3580689210488653","authorId":"3580689210488653","name":"SilentWarrio","avatar":"https://static.tigerbbs.com/c904a9b7d64fe6eb5230d2a57a74ffee","vip":1,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3580689210488653","idStr":"3580689210488653"},"htmlText":"Good Buy?&nbsp;","listText":"Good Buy?&nbsp;","text":"Good Buy?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600852838","repostId":1153242523,"repostType":4,"repost":{"id":"1153242523","kind":"news","pubTimestamp":1638063498,"share":"https://www.laohu8.com/m/news/1153242523?lang=&edition=full","pubTime":"2021-11-28 09:38","market":"us","language":"en","title":"US IPO Week Ahead: December kicks off with a 1 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1153242523","media":"Renaissance Capital","summary":"The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise ","content":"<p>The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise $30 million in the first week of December.</p>\n<p>While the calendar is quiet at the moment, several IPOs are eligible to launch on Monday, including Indian IT services provider&nbsp;<b>Coforge</b>&nbsp;(CFRG.RC), cloud infrastructure platform&nbsp;<b>HashiCorp</b>&nbsp;(HCP), luxury fashion e-tailer&nbsp;<b>Rue Gilt Group</b>&nbsp;(RGG), rugged apparel brand&nbsp;<b>5.11 ABR</b>(VXI), and Florida-based insurer&nbsp;<b>TypTapInsurance Group</b>&nbsp;(TYTP).</p>\n<p>Phase 1-ready biotech&nbsp;<b>Nuvectis Pharma</b>&nbsp;(NVCT) plans to raise $30 million at a $160 million market cap. The company is initially focused the development of innovative precision medicines for the treatment of serious unmet medical needs in oncology. Nuvectis is currently developing two preclinical candidates, with its lead candidate expected to begin a Phase 1 trial in the 4Q21.</p>\n<p><img src=\"https://static.tigerbbs.com/ebedc817c5c3858bec4f16c6152bfce8\" tg-width=\"936\" tg-height=\"163\" referrerpolicy=\"no-referrer\"></p>\n<p>Street research is expected to 12 companies in the week ahead, and lock-up periods will be expiring for up to four companies. For access to Street research and lock-up dates,sign up for a free trial of IPO Pro.</p>\n<p><b>IPO Market Snapshot</b></p>\n<p>The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 11/24/2021, the Renaissance IPO Index was down 1.1% year-to-date, while the S&amp;P 500 was up 25.2%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Moderna (MRNA). The Renaissance International IPO Index was down 22.4% year-to-date, while the ACWX was up 7.4%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.</p>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: December kicks off with a 1 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: December kicks off with a 1 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-28 09:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/89065/US-IPO-Week-Ahead-December-kicks-off-with-a-1-IPO-week><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise $30 million in the first week of December.\nWhile the calendar is quiet at the moment, several IPOs ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/89065/US-IPO-Week-Ahead-December-kicks-off-with-a-1-IPO-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVCT":"Nuvectis Pharma, Inc."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/89065/US-IPO-Week-Ahead-December-kicks-off-with-a-1-IPO-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1153242523","content_text":"The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise $30 million in the first week of December.\nWhile the calendar is quiet at the moment, several IPOs are eligible to launch on Monday, including Indian IT services provider Coforge (CFRG.RC), cloud infrastructure platform HashiCorp (HCP), luxury fashion e-tailer Rue Gilt Group (RGG), rugged apparel brand 5.11 ABR(VXI), and Florida-based insurer TypTapInsurance Group (TYTP).\nPhase 1-ready biotech Nuvectis Pharma (NVCT) plans to raise $30 million at a $160 million market cap. The company is initially focused the development of innovative precision medicines for the treatment of serious unmet medical needs in oncology. Nuvectis is currently developing two preclinical candidates, with its lead candidate expected to begin a Phase 1 trial in the 4Q21.\n\nStreet research is expected to 12 companies in the week ahead, and lock-up periods will be expiring for up to four companies. For access to Street research and lock-up dates,sign up for a free trial of IPO Pro.\nIPO Market Snapshot\nThe Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 11/24/2021, the Renaissance IPO Index was down 1.1% year-to-date, while the S&P 500 was up 25.2%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Moderna (MRNA). The Renaissance International IPO Index was down 22.4% year-to-date, while the ACWX was up 7.4%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":600851137,"gmtCreate":1638141460335,"gmtModify":1638141460449,"author":{"id":"4092698747642690","authorId":"4092698747642690","name":"47776e2c","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"4092698747642690","idStr":"4092698747642690"},"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600851137","repostId":1153242523,"repostType":4,"repost":{"id":"1153242523","kind":"news","pubTimestamp":1638063498,"share":"https://www.laohu8.com/m/news/1153242523?lang=&edition=full","pubTime":"2021-11-28 09:38","market":"us","language":"en","title":"US IPO Week Ahead: December kicks off with a 1 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1153242523","media":"Renaissance Capital","summary":"The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise ","content":"<p>The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise $30 million in the first week of December.</p>\n<p>While the calendar is quiet at the moment, several IPOs are eligible to launch on Monday, including Indian IT services provider&nbsp;<b>Coforge</b>&nbsp;(CFRG.RC), cloud infrastructure platform&nbsp;<b>HashiCorp</b>&nbsp;(HCP), luxury fashion e-tailer&nbsp;<b>Rue Gilt Group</b>&nbsp;(RGG), rugged apparel brand&nbsp;<b>5.11 ABR</b>(VXI), and Florida-based insurer&nbsp;<b>TypTapInsurance Group</b>&nbsp;(TYTP).</p>\n<p>Phase 1-ready biotech&nbsp;<b>Nuvectis Pharma</b>&nbsp;(NVCT) plans to raise $30 million at a $160 million market cap. The company is initially focused the development of innovative precision medicines for the treatment of serious unmet medical needs in oncology. Nuvectis is currently developing two preclinical candidates, with its lead candidate expected to begin a Phase 1 trial in the 4Q21.</p>\n<p><img src=\"https://static.tigerbbs.com/ebedc817c5c3858bec4f16c6152bfce8\" tg-width=\"936\" tg-height=\"163\" referrerpolicy=\"no-referrer\"></p>\n<p>Street research is expected to 12 companies in the week ahead, and lock-up periods will be expiring for up to four companies. For access to Street research and lock-up dates,sign up for a free trial of IPO Pro.</p>\n<p><b>IPO Market Snapshot</b></p>\n<p>The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 11/24/2021, the Renaissance IPO Index was down 1.1% year-to-date, while the S&amp;P 500 was up 25.2%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Moderna (MRNA). The Renaissance International IPO Index was down 22.4% year-to-date, while the ACWX was up 7.4%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.</p>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: December kicks off with a 1 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: December kicks off with a 1 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-28 09:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/89065/US-IPO-Week-Ahead-December-kicks-off-with-a-1-IPO-week><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise $30 million in the first week of December.\nWhile the calendar is quiet at the moment, several IPOs ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/89065/US-IPO-Week-Ahead-December-kicks-off-with-a-1-IPO-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVCT":"Nuvectis Pharma, Inc."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/89065/US-IPO-Week-Ahead-December-kicks-off-with-a-1-IPO-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1153242523","content_text":"The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise $30 million in the first week of December.\nWhile the calendar is quiet at the moment, several IPOs are eligible to launch on Monday, including Indian IT services provider Coforge (CFRG.RC), cloud infrastructure platform HashiCorp (HCP), luxury fashion e-tailer Rue Gilt Group (RGG), rugged apparel brand 5.11 ABR(VXI), and Florida-based insurer TypTapInsurance Group (TYTP).\nPhase 1-ready biotech Nuvectis Pharma (NVCT) plans to raise $30 million at a $160 million market cap. The company is initially focused the development of innovative precision medicines for the treatment of serious unmet medical needs in oncology. Nuvectis is currently developing two preclinical candidates, with its lead candidate expected to begin a Phase 1 trial in the 4Q21.\n\nStreet research is expected to 12 companies in the week ahead, and lock-up periods will be expiring for up to four companies. For access to Street research and lock-up dates,sign up for a free trial of IPO Pro.\nIPO Market Snapshot\nThe Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 11/24/2021, the Renaissance IPO Index was down 1.1% year-to-date, while the S&P 500 was up 25.2%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Moderna (MRNA). The Renaissance International IPO Index was down 22.4% year-to-date, while the ACWX was up 7.4%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":600821161,"gmtCreate":1638140533498,"gmtModify":1638140533954,"author":{"id":"3571959390768435","authorId":"3571959390768435","name":"stormlee","avatar":"https://static.tigerbbs.com/80629ef9648273c0d6465aee66dbd98a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3571959390768435","idStr":"3571959390768435"},"htmlText":"Pls like thanks&nbsp;","listText":"Pls like thanks&nbsp;","text":"Pls like thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/600821161","repostId":1153242523,"repostType":4,"repost":{"id":"1153242523","kind":"news","pubTimestamp":1638063498,"share":"https://www.laohu8.com/m/news/1153242523?lang=&edition=full","pubTime":"2021-11-28 09:38","market":"us","language":"en","title":"US IPO Week Ahead: December kicks off with a 1 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1153242523","media":"Renaissance Capital","summary":"The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise ","content":"<p>The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise $30 million in the first week of December.</p>\n<p>While the calendar is quiet at the moment, several IPOs are eligible to launch on Monday, including Indian IT services provider&nbsp;<b>Coforge</b>&nbsp;(CFRG.RC), cloud infrastructure platform&nbsp;<b>HashiCorp</b>&nbsp;(HCP), luxury fashion e-tailer&nbsp;<b>Rue Gilt Group</b>&nbsp;(RGG), rugged apparel brand&nbsp;<b>5.11 ABR</b>(VXI), and Florida-based insurer&nbsp;<b>TypTapInsurance Group</b>&nbsp;(TYTP).</p>\n<p>Phase 1-ready biotech&nbsp;<b>Nuvectis Pharma</b>&nbsp;(NVCT) plans to raise $30 million at a $160 million market cap. The company is initially focused the development of innovative precision medicines for the treatment of serious unmet medical needs in oncology. Nuvectis is currently developing two preclinical candidates, with its lead candidate expected to begin a Phase 1 trial in the 4Q21.</p>\n<p><img src=\"https://static.tigerbbs.com/ebedc817c5c3858bec4f16c6152bfce8\" tg-width=\"936\" tg-height=\"163\" referrerpolicy=\"no-referrer\"></p>\n<p>Street research is expected to 12 companies in the week ahead, and lock-up periods will be expiring for up to four companies. For access to Street research and lock-up dates,sign up for a free trial of IPO Pro.</p>\n<p><b>IPO Market Snapshot</b></p>\n<p>The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 11/24/2021, the Renaissance IPO Index was down 1.1% year-to-date, while the S&amp;P 500 was up 25.2%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Moderna (MRNA). The Renaissance International IPO Index was down 22.4% year-to-date, while the ACWX was up 7.4%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.</p>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: December kicks off with a 1 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: December kicks off with a 1 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-28 09:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/89065/US-IPO-Week-Ahead-December-kicks-off-with-a-1-IPO-week><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise $30 million in the first week of December.\nWhile the calendar is quiet at the moment, several IPOs ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/89065/US-IPO-Week-Ahead-December-kicks-off-with-a-1-IPO-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVCT":"Nuvectis Pharma, Inc."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/89065/US-IPO-Week-Ahead-December-kicks-off-with-a-1-IPO-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1153242523","content_text":"The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise $30 million in the first week of December.\nWhile the calendar is quiet at the moment, several IPOs are eligible to launch on Monday, including Indian IT services provider Coforge (CFRG.RC), cloud infrastructure platform HashiCorp (HCP), luxury fashion e-tailer Rue Gilt Group (RGG), rugged apparel brand 5.11 ABR(VXI), and Florida-based insurer TypTapInsurance Group (TYTP).\nPhase 1-ready biotech Nuvectis Pharma (NVCT) plans to raise $30 million at a $160 million market cap. The company is initially focused the development of innovative precision medicines for the treatment of serious unmet medical needs in oncology. Nuvectis is currently developing two preclinical candidates, with its lead candidate expected to begin a Phase 1 trial in the 4Q21.\n\nStreet research is expected to 12 companies in the week ahead, and lock-up periods will be expiring for up to four companies. For access to Street research and lock-up dates,sign up for a free trial of IPO Pro.\nIPO Market Snapshot\nThe Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 11/24/2021, the Renaissance IPO Index was down 1.1% year-to-date, while the S&P 500 was up 25.2%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Moderna (MRNA). The Renaissance International IPO Index was down 22.4% year-to-date, while the ACWX was up 7.4%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6761317,"gmtCreate":1638142473272,"gmtModify":1638142473320,"authorId":3567307840510045,"author":{"id":3567307840510045,"idStr":"3567307840510045","authorId":3567307840510045,"name":"JeremyKok","avatar":"https://static.tigerbbs.com/01b03a485f83b6b2615fad8ac9b87bf4","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":600821161,"type":1,"supId":0,"prevId":0,"content":"hi. please like and comment back. thank you.","text":"hi. please like and comment back. thank you.","html":"hi. please like and comment back. thank you."}],"langContent":"CN"},{"id":600836839,"gmtCreate":1638115012698,"gmtModify":1638115012774,"author":{"id":"3575024004895861","authorId":"3575024004895861","name":"Yannick","avatar":"https://static.tigerbbs.com/b8bcd137597d0a92ada6ef564b84dd48","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3575024004895861","idStr":"3575024004895861"},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/600836839","repostId":1153242523,"repostType":4,"repost":{"id":"1153242523","kind":"news","pubTimestamp":1638063498,"share":"https://www.laohu8.com/m/news/1153242523?lang=&edition=full","pubTime":"2021-11-28 09:38","market":"us","language":"en","title":"US IPO Week Ahead: December kicks off with a 1 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1153242523","media":"Renaissance Capital","summary":"The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise ","content":"<p>The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise $30 million in the first week of December.</p>\n<p>While the calendar is quiet at the moment, several IPOs are eligible to launch on Monday, including Indian IT services provider&nbsp;<b>Coforge</b>&nbsp;(CFRG.RC), cloud infrastructure platform&nbsp;<b>HashiCorp</b>&nbsp;(HCP), luxury fashion e-tailer&nbsp;<b>Rue Gilt Group</b>&nbsp;(RGG), rugged apparel brand&nbsp;<b>5.11 ABR</b>(VXI), and Florida-based insurer&nbsp;<b>TypTapInsurance Group</b>&nbsp;(TYTP).</p>\n<p>Phase 1-ready biotech&nbsp;<b>Nuvectis Pharma</b>&nbsp;(NVCT) plans to raise $30 million at a $160 million market cap. The company is initially focused the development of innovative precision medicines for the treatment of serious unmet medical needs in oncology. Nuvectis is currently developing two preclinical candidates, with its lead candidate expected to begin a Phase 1 trial in the 4Q21.</p>\n<p><img src=\"https://static.tigerbbs.com/ebedc817c5c3858bec4f16c6152bfce8\" tg-width=\"936\" tg-height=\"163\" referrerpolicy=\"no-referrer\"></p>\n<p>Street research is expected to 12 companies in the week ahead, and lock-up periods will be expiring for up to four companies. For access to Street research and lock-up dates,sign up for a free trial of IPO Pro.</p>\n<p><b>IPO Market Snapshot</b></p>\n<p>The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 11/24/2021, the Renaissance IPO Index was down 1.1% year-to-date, while the S&amp;P 500 was up 25.2%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Moderna (MRNA). The Renaissance International IPO Index was down 22.4% year-to-date, while the ACWX was up 7.4%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.</p>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: December kicks off with a 1 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: December kicks off with a 1 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-28 09:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/89065/US-IPO-Week-Ahead-December-kicks-off-with-a-1-IPO-week><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise $30 million in the first week of December.\nWhile the calendar is quiet at the moment, several IPOs ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/89065/US-IPO-Week-Ahead-December-kicks-off-with-a-1-IPO-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVCT":"Nuvectis Pharma, Inc."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/89065/US-IPO-Week-Ahead-December-kicks-off-with-a-1-IPO-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1153242523","content_text":"The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise $30 million in the first week of December.\nWhile the calendar is quiet at the moment, several IPOs are eligible to launch on Monday, including Indian IT services provider Coforge (CFRG.RC), cloud infrastructure platform HashiCorp (HCP), luxury fashion e-tailer Rue Gilt Group (RGG), rugged apparel brand 5.11 ABR(VXI), and Florida-based insurer TypTapInsurance Group (TYTP).\nPhase 1-ready biotech Nuvectis Pharma (NVCT) plans to raise $30 million at a $160 million market cap. The company is initially focused the development of innovative precision medicines for the treatment of serious unmet medical needs in oncology. Nuvectis is currently developing two preclinical candidates, with its lead candidate expected to begin a Phase 1 trial in the 4Q21.\n\nStreet research is expected to 12 companies in the week ahead, and lock-up periods will be expiring for up to four companies. For access to Street research and lock-up dates,sign up for a free trial of IPO Pro.\nIPO Market Snapshot\nThe Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 11/24/2021, the Renaissance IPO Index was down 1.1% year-to-date, while the S&P 500 was up 25.2%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Moderna (MRNA). The Renaissance International IPO Index was down 22.4% year-to-date, while the ACWX was up 7.4%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6942183,"gmtCreate":1639235972837,"gmtModify":1639235972869,"authorId":3575024004895861,"author":{"id":3575024004895861,"idStr":"3575024004895861","authorId":3575024004895861,"name":"Yannick","avatar":"https://static.tigerbbs.com/b8bcd137597d0a92ada6ef564b84dd48","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":600836839,"type":1,"supId":6761318,"prevId":0,"content":"<u>tks</u>","text":"<u>tks</u>","html":"<u>tks</u>"},{"id":6762700,"gmtCreate":1638145938280,"gmtModify":1638145938312,"authorId":3581730902365980,"author":{"id":3581730902365980,"idStr":"3581730902365980","authorId":3581730902365980,"name":"7d918508","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":600836839,"type":1,"supId":0,"prevId":0,"content":"<u>Ok</u>","text":"<u>Ok</u>","html":"<u>Ok</u>"},{"id":6761318,"gmtCreate":1638142478928,"gmtModify":1638142478962,"authorId":3567307840510045,"author":{"id":3567307840510045,"idStr":"3567307840510045","authorId":3567307840510045,"name":"JeremyKok","avatar":"https://static.tigerbbs.com/01b03a485f83b6b2615fad8ac9b87bf4","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":600836839,"type":1,"supId":0,"prevId":0,"content":"hi. please like and comment back. thank you.","text":"hi. please like and comment back. thank you.","html":"hi. please like and comment back. thank you."},{"id":6760606,"gmtCreate":1638140539524,"gmtModify":1638140539613,"authorId":3571959390768435,"author":{"id":3571959390768435,"idStr":"3571959390768435","authorId":3571959390768435,"name":"stormlee","avatar":"https://static.tigerbbs.com/80629ef9648273c0d6465aee66dbd98a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":600836839,"type":1,"supId":0,"prevId":0,"content":"Pls like thanks","text":"Pls like thanks","html":"Pls like thanks"}],"langContent":"CN"},{"id":600801340,"gmtCreate":1638110276875,"gmtModify":1638110276992,"author":{"id":"3584157491931754","authorId":"3584157491931754","name":"bostonxsgp","avatar":"https://static.tigerbbs.com/55d82efabeabddb18cc2d6ca7a71a36f","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3584157491931754","idStr":"3584157491931754"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/600801340","repostId":1153242523,"repostType":4,"repost":{"id":"1153242523","kind":"news","pubTimestamp":1638063498,"share":"https://www.laohu8.com/m/news/1153242523?lang=&edition=full","pubTime":"2021-11-28 09:38","market":"us","language":"en","title":"US IPO Week Ahead: December kicks off with a 1 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1153242523","media":"Renaissance Capital","summary":"The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise ","content":"<p>The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise $30 million in the first week of December.</p>\n<p>While the calendar is quiet at the moment, several IPOs are eligible to launch on Monday, including Indian IT services provider&nbsp;<b>Coforge</b>&nbsp;(CFRG.RC), cloud infrastructure platform&nbsp;<b>HashiCorp</b>&nbsp;(HCP), luxury fashion e-tailer&nbsp;<b>Rue Gilt Group</b>&nbsp;(RGG), rugged apparel brand&nbsp;<b>5.11 ABR</b>(VXI), and Florida-based insurer&nbsp;<b>TypTapInsurance Group</b>&nbsp;(TYTP).</p>\n<p>Phase 1-ready biotech&nbsp;<b>Nuvectis Pharma</b>&nbsp;(NVCT) plans to raise $30 million at a $160 million market cap. The company is initially focused the development of innovative precision medicines for the treatment of serious unmet medical needs in oncology. Nuvectis is currently developing two preclinical candidates, with its lead candidate expected to begin a Phase 1 trial in the 4Q21.</p>\n<p><img src=\"https://static.tigerbbs.com/ebedc817c5c3858bec4f16c6152bfce8\" tg-width=\"936\" tg-height=\"163\" referrerpolicy=\"no-referrer\"></p>\n<p>Street research is expected to 12 companies in the week ahead, and lock-up periods will be expiring for up to four companies. For access to Street research and lock-up dates,sign up for a free trial of IPO Pro.</p>\n<p><b>IPO Market Snapshot</b></p>\n<p>The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 11/24/2021, the Renaissance IPO Index was down 1.1% year-to-date, while the S&amp;P 500 was up 25.2%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Moderna (MRNA). The Renaissance International IPO Index was down 22.4% year-to-date, while the ACWX was up 7.4%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.</p>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: December kicks off with a 1 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: December kicks off with a 1 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-28 09:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/89065/US-IPO-Week-Ahead-December-kicks-off-with-a-1-IPO-week><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise $30 million in the first week of December.\nWhile the calendar is quiet at the moment, several IPOs ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/89065/US-IPO-Week-Ahead-December-kicks-off-with-a-1-IPO-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVCT":"Nuvectis Pharma, Inc."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/89065/US-IPO-Week-Ahead-December-kicks-off-with-a-1-IPO-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1153242523","content_text":"The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise $30 million in the first week of December.\nWhile the calendar is quiet at the moment, several IPOs are eligible to launch on Monday, including Indian IT services provider Coforge (CFRG.RC), cloud infrastructure platform HashiCorp (HCP), luxury fashion e-tailer Rue Gilt Group (RGG), rugged apparel brand 5.11 ABR(VXI), and Florida-based insurer TypTapInsurance Group (TYTP).\nPhase 1-ready biotech Nuvectis Pharma (NVCT) plans to raise $30 million at a $160 million market cap. The company is initially focused the development of innovative precision medicines for the treatment of serious unmet medical needs in oncology. Nuvectis is currently developing two preclinical candidates, with its lead candidate expected to begin a Phase 1 trial in the 4Q21.\n\nStreet research is expected to 12 companies in the week ahead, and lock-up periods will be expiring for up to four companies. For access to Street research and lock-up dates,sign up for a free trial of IPO Pro.\nIPO Market Snapshot\nThe Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 11/24/2021, the Renaissance IPO Index was down 1.1% year-to-date, while the S&P 500 was up 25.2%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Moderna (MRNA). The Renaissance International IPO Index was down 22.4% year-to-date, while the ACWX was up 7.4%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6759559,"gmtCreate":1638117720571,"gmtModify":1638117720655,"authorId":3576212227172632,"author":{"id":3576212227172632,"idStr":"3576212227172632","authorId":3576212227172632,"name":"ToTheMOON","avatar":"https://static.tigerbbs.com/7769f4b8d26aa1903d8784e79b05b4df","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":600801340,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"},{"id":6758857,"gmtCreate":1638112121234,"gmtModify":1638112121270,"authorId":3586473514667147,"author":{"id":3586473514667147,"idStr":"3586473514667147","authorId":3586473514667147,"name":"gky","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":600801340,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"CN"},{"id":600134713,"gmtCreate":1638085346744,"gmtModify":1638085414184,"author":{"id":"4089205014499330","authorId":"4089205014499330","name":"SamYYL","avatar":"https://static.tigerbbs.com/c38b79dfd54364065e7068bc7e80dc9f","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"4089205014499330","idStr":"4089205014499330"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/600134713","repostId":1153242523,"repostType":4,"repost":{"id":"1153242523","kind":"news","pubTimestamp":1638063498,"share":"https://www.laohu8.com/m/news/1153242523?lang=&edition=full","pubTime":"2021-11-28 09:38","market":"us","language":"en","title":"US IPO Week Ahead: December kicks off with a 1 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1153242523","media":"Renaissance Capital","summary":"The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise ","content":"<p>The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise $30 million in the first week of December.</p>\n<p>While the calendar is quiet at the moment, several IPOs are eligible to launch on Monday, including Indian IT services provider&nbsp;<b>Coforge</b>&nbsp;(CFRG.RC), cloud infrastructure platform&nbsp;<b>HashiCorp</b>&nbsp;(HCP), luxury fashion e-tailer&nbsp;<b>Rue Gilt Group</b>&nbsp;(RGG), rugged apparel brand&nbsp;<b>5.11 ABR</b>(VXI), and Florida-based insurer&nbsp;<b>TypTapInsurance Group</b>&nbsp;(TYTP).</p>\n<p>Phase 1-ready biotech&nbsp;<b>Nuvectis Pharma</b>&nbsp;(NVCT) plans to raise $30 million at a $160 million market cap. The company is initially focused the development of innovative precision medicines for the treatment of serious unmet medical needs in oncology. Nuvectis is currently developing two preclinical candidates, with its lead candidate expected to begin a Phase 1 trial in the 4Q21.</p>\n<p><img src=\"https://static.tigerbbs.com/ebedc817c5c3858bec4f16c6152bfce8\" tg-width=\"936\" tg-height=\"163\" referrerpolicy=\"no-referrer\"></p>\n<p>Street research is expected to 12 companies in the week ahead, and lock-up periods will be expiring for up to four companies. For access to Street research and lock-up dates,sign up for a free trial of IPO Pro.</p>\n<p><b>IPO Market Snapshot</b></p>\n<p>The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 11/24/2021, the Renaissance IPO Index was down 1.1% year-to-date, while the S&amp;P 500 was up 25.2%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Moderna (MRNA). The Renaissance International IPO Index was down 22.4% year-to-date, while the ACWX was up 7.4%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.</p>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: December kicks off with a 1 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: December kicks off with a 1 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-28 09:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/89065/US-IPO-Week-Ahead-December-kicks-off-with-a-1-IPO-week><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise $30 million in the first week of December.\nWhile the calendar is quiet at the moment, several IPOs ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/89065/US-IPO-Week-Ahead-December-kicks-off-with-a-1-IPO-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVCT":"Nuvectis Pharma, Inc."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/89065/US-IPO-Week-Ahead-December-kicks-off-with-a-1-IPO-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1153242523","content_text":"The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise $30 million in the first week of December.\nWhile the calendar is quiet at the moment, several IPOs are eligible to launch on Monday, including Indian IT services provider Coforge (CFRG.RC), cloud infrastructure platform HashiCorp (HCP), luxury fashion e-tailer Rue Gilt Group (RGG), rugged apparel brand 5.11 ABR(VXI), and Florida-based insurer TypTapInsurance Group (TYTP).\nPhase 1-ready biotech Nuvectis Pharma (NVCT) plans to raise $30 million at a $160 million market cap. The company is initially focused the development of innovative precision medicines for the treatment of serious unmet medical needs in oncology. Nuvectis is currently developing two preclinical candidates, with its lead candidate expected to begin a Phase 1 trial in the 4Q21.\n\nStreet research is expected to 12 companies in the week ahead, and lock-up periods will be expiring for up to four companies. For access to Street research and lock-up dates,sign up for a free trial of IPO Pro.\nIPO Market Snapshot\nThe Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 11/24/2021, the Renaissance IPO Index was down 1.1% year-to-date, while the S&P 500 was up 25.2%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Moderna (MRNA). The Renaissance International IPO Index was down 22.4% year-to-date, while the ACWX was up 7.4%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6789277,"gmtCreate":1638310874925,"gmtModify":1638310874957,"authorId":3571959390768435,"author":{"id":3571959390768435,"idStr":"3571959390768435","authorId":3571959390768435,"name":"stormlee","avatar":"https://static.tigerbbs.com/80629ef9648273c0d6465aee66dbd98a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":4089205014499330,"repliedAuthor":{"id":4089205014499330,"idStr":"4089205014499330","authorId":4089205014499330,"name":"SamYYL","avatar":"https://static.tigerbbs.com/c38b79dfd54364065e7068bc7e80dc9f","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":600134713,"type":1,"supId":6760610,"prevId":6771368,"content":"<u>Tq</u>","text":"<u>Tq</u>","html":"<u>Tq</u>"},{"id":6771368,"gmtCreate":1638195607045,"gmtModify":1638195607149,"authorId":4089205014499330,"author":{"id":4089205014499330,"idStr":"4089205014499330","authorId":4089205014499330,"name":"SamYYL","avatar":"https://static.tigerbbs.com/c38b79dfd54364065e7068bc7e80dc9f","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":600134713,"type":1,"supId":6760610,"prevId":0,"content":"<u>thanks</u>","text":"<u>thanks</u>","html":"<u>thanks</u>"},{"id":6760610,"gmtCreate":1638140547921,"gmtModify":1638140547949,"authorId":3571959390768435,"author":{"id":3571959390768435,"idStr":"3571959390768435","authorId":3571959390768435,"name":"stormlee","avatar":"https://static.tigerbbs.com/80629ef9648273c0d6465aee66dbd98a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":600134713,"type":1,"supId":0,"prevId":0,"content":"Pls like thanks","text":"Pls like thanks","html":"Pls like thanks"},{"id":6757276,"gmtCreate":1638099241724,"gmtModify":1638099241750,"authorId":3585038405943602,"author":{"id":3585038405943602,"idStr":"3585038405943602","authorId":3585038405943602,"name":"Ahleepapa","avatar":"https://static.tigerbbs.com/dcc1fea9c38112b58c68a2d96017330b","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":600134713,"type":1,"supId":0,"prevId":0,"content":"Short","text":"Short","html":"Short"},{"id":6756400,"gmtCreate":1638088895587,"gmtModify":1638088895620,"authorId":3579572647008782,"author":{"id":3579572647008782,"idStr":"3579572647008782","authorId":3579572647008782,"name":"Mtan23","avatar":"https://static.tigerbbs.com/21a2ddfc414d0d3eab50e895e776bf23","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":600134713,"type":1,"supId":0,"prevId":0,"content":"Yes","text":"Yes","html":"Yes"}],"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":690,"commentSize":51,"repostSize":0,"favoriteSize":1,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1153242523"}